Skip to main content

ERRATUM article

Front. Immunol., 04 July 2022
Sec. Cancer Immunity and Immunotherapy

Erratum: Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer

Frontiers Production Office Frontiers Production Office
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on:
Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer.

Pagliarulo F, Cheng PF, Brugger L, van Dijk N, van den Heijden M, Levesque MP, Silina K and van den Broek M (2022) . 12:793992. doi: 10.3389/fimmu.2021.793992

Due to a production error, Supplementary Figures 2,3,5,6,7,8 and 9 were not published. The publisher apologizes for this mistake.

The original version of this article has been updated.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2022.975797/full#supplementary-material

Keywords: tertiary lymphoid structures, lymphoid neogenesis, tumor mutational burden, cancer immunology, immune checkpoint inhibition, survival, prognosis, tumor microenvironment

Citation: Frontiers Production Office (2022) Erratum: Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer. Front. Immunol. 13:975797. doi: 10.3389/fimmu.2022.975797

Received: 22 June 2022; Accepted: 22 June 2022;
Published: 04 July 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: production.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.